Author： Lennon Frances E Salgia Ravi
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.23, Iss.5, 2014-05, pp. : 675-692
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Targeting signaling pathways in lung cancer therapy
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. :
Access to resources
Recommend
Metformin in lung cancer: rationale for a combination therapy
By Morgillo Floriana Sasso Ferdinando Carlo Della Corte Carminia Maria Festino Lucia Manzo Anna Martinelli Erika Troiani Teresa Capuano Annalisa Ciardiello Fortunato
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. :
Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. :
Role of PARP Inhibitors in Cancer Biology and Therapy
Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. :